Agnieszka Szuster-Ciesielska
Overview
Explore the profile of Agnieszka Szuster-Ciesielska including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
376
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sztandera-Tymoczek M, Wdowiak-Wrobel S, Swiderska U, Palusinska-Szysz M, Szuster-Ciesielska A
J Inflamm Res
. 2025 Jan;
18:1107-1125.
PMID: 39881795
Purpose: Allergic diseases have escalated to epidemic levels worldwide, impacting nearly 30% of the global population. Fungi are a significant source of allergens responsible for up to 6% of respiratory...
2.
Pietrzak L, Polok K, Halik R, Szuster-Ciesielska A, Szczeklik W
Pol Arch Intern Med
. 2024 Feb;
134(2).
PMID: 38415513
No abstract available.
3.
Rzymski P, Szuster-Ciesielska A
Reumatologia
. 2023 Nov;
61(5):327-330.
PMID: 37970114
No abstract available.
4.
Sztandera-Tymoczek M, Wdowiak-Wrobel S, Swiderska U, Palusinska-Szysz M, Szuster-Ciesielska A
J Inflamm Res
. 2023 Nov;
16:5039-5060.
PMID: 37933334
Purpose: Allergic diseases have reached epidemic proportions globally, affecting nearly 30% of the world's population. One of the most prominent sources of allergens is fungi, causing up to 6% of...
5.
Kowalczyk B, Petzold M, Kaczynski Z, Szuster-Ciesielska A, Luchowski R, Gruszecki W, et al.
Int J Mol Sci
. 2023 Oct;
24(19).
PMID: 37834049
is the primary causative agent of Legionnaires' disease. The mutant-type strain interrupted in the ORF7 gene region responsible for the lipopolysaccharide biosynthesis of the strain Heysham-1, lacking the -acetyl groups...
6.
Pietrzak L, Polok K, Halik R, Szuster-Ciesielska A, Szczeklik W
Pol Arch Intern Med
. 2023 Sep;
133(9).
PMID: 37772712
No abstract available.
7.
Sztandera-Tymoczek M, Szuster-Ciesielska A
J Fungi (Basel)
. 2023 May;
9(5).
PMID: 37233255
The incidence of allergic diseases worldwide is rapidly increasing, making allergies a modern pandemic. This article intends to review published reports addressing the role of fungi as causative agents in...
8.
Pietrzak L, Polok K, Halik R, Szuster-Ciesielska A, Szczeklik W
Pol Arch Intern Med
. 2023 Mar;
133(9).
PMID: 36876868
Introduction: Development of vaccines was a turning point of the COVID‑19 pandemic. In this study, we describe the course of the vaccination program in Poland and the effectiveness of the...
9.
Rzymski P, Szuster-Ciesielska A, Dzieciatkowski T, Gwenzi W, Fal A
J Med Virol
. 2023 Feb;
95(2):e28572.
PMID: 36762592
Messenger RNA (mRNA) vaccines against COVID-19 are the first authorized biological preparations developed using this platform. During the pandemic, their administration has been proven to be a life-saving intervention. Here,...
10.
Rzymski P, Szuster-Ciesielska A
Vaccines (Basel)
. 2022 Jul;
10(7).
PMID: 35891234
By June 2022, COVID-19 vaccine coverage in low-income countries remained low, while the emergence of the highly-transmissible but less clinically-severe Omicron lineage of SARS-CoV-2 has led to the assumption expressed...